Cardiovascular AgentsCaduet (amlodipine/atorvastatin) Tablets
Manufacturer: Pfizer Inc.
Drug Approval Classification: Original New Drug Application (Approval Date: 01/30/04)
Indication: This new drug application provides for the use of Caduet (amlodipine besylate/atorvastatin calcium) in patients for whom treatment with both amlodipine and atorvastatin is appropriate as indicated.
Dosing: Caduet tablets contain amlodipine besylate and atorvastatin calcium equivalent to amlodipine and atorvastatin in the dose strengths described below:
Tablet Strength (amlodipine besylate/ atorvastatin calcium) mg:
Medscape Pharmacists. 2004;5(1) © 2004 Medscape
Cite this: March 2004 - Medscape - Apr 06, 2004.